Please contact Scott Hall at email@example.com or 202-463-5817.
U.S. Chamber Supports Congressional Copyright Office Bill
WASHINGTON, D.C. — U.S. Chamber of Commerce Executive Vice President of the Global Intellectual Property Center Mark Elliot released the following statement in support of the Register of Copyrights Selection and Accountability Act, the result of a bipartisan, bicameral effort led by House Judiciary Committee Chairman Bob Goodlatte (R-Va.) and Ranking Member John Conyers (D-Mich.), Senate Judiciary Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Dianne Feinstein (D-Calif.), and Senate Judiciary Committee Member Patrick Leahy (D-Vt.).:
“Innovative and creative industries are encouraged by Congress’ commitment to the ongoing process to modernize the U.S. Copyright Office. The office plays a critical role in fostering American creativity and innovation: copyright-intensive industries support 5.6 million jobs in the U.S. alone. It is extremely important that Congress continue its work on office modernization going forward in order to provide the office with the right leadership and IT capabilities to better serve the American people and companies. We applaud congressional leaders on the introduction of this bipartisan bill as an important first step in this process, and we will continue to work with them as they seek to strengthen and improve our nation’s Copyright Office.”
The Chamber’s Global Intellectual Property Center is working around the world to champion intellectual property (IP) rights as vital to creating jobs, saving lives, advancing global economic growth, and generating breakthrough solutions to global challenges.
The U.S. Chamber of Commerce is the world’s largest business federation representing the interests of more than 3 million businesses of all sizes, sectors, and regions, as well as state and local chambers and industry associations.
Global Innovation Policy Center @globalIPcenter 22h
“[An #IP waiver] would be a destructive policy even if it were necessary, but it is not necessary — it is not even likely to prove beneficial for the purpose at hand, which is helping to speed the pace of global vaccinations.” https://t.co/utPA1XuuqU